Pfizer Inc. (PFE) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Pfizer Inc. (PFE) carries a Roarable Rating of C (Hold) with 65/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How PFE Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $62.58B | 74.3% | 14.7% | $7.77B | $9.07B | 4.9% |
| FY 2024 | $63.63B | 71.9% | 14.9% | $8.03B | $9.84B | 5.2% |
| FY 2023 | $50.91B | 44% | 4.9% | $2.12B | $6.41B | 3.5% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring PFE)
- ✓Live walkthrough of PFE's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
PFE Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -1.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on PFE today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for PFE. Explore sector supply chains on /butterfly.
PFE Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Pfizer Inc. (PFE)?
In FY 2025 (10-K), PFE converted $62.6B of revenue into a 74.3% gross margin, 14.7% operating margin, and $9.1B in free cash flow (14.5% FCF margin).